#1292ef

SHILPA MEDICARE LIMITED

#f9f9f9

Omprakash Inani

Vishnukant Bhutada

Sushil Bajaj

Sharath Reddy

R. K. Somani

Subir Chopra

Dilip Chavan

Lav Kumar

Venkatesh Katakam

Navneet Mundada

Ratna Phani Ayalasomayajula

#87c5f2

Finance

Operations

Sales & Marketing

Subsidiaries

Shilpa Therapeutics Private Limited

INM Technologies

Shilpa Medicare Limited is engaged in the business of manufacturing of bulk drugs or active pharmaceutical ingredient (API) and intermediates, and wind power generation. The Company's segments include Bulk Drug/Intermediates and Energy. It offers 3a 7b Dihydroxy. The Company deals with APIs, Intermediates, Formulations, New Drug Delivery Systems, Peptides/Biotech products and Specialty Chemicals. The Company supplies oncology/non-oncology APIs and intermediates. Its oncology API products include Anastrozole, Axitinib, Azacitidine, Abiraterone Acetate, Bicalutamide, Bortezomib, Busulphan, Cabazitaxel Amorphous, Capecitabine, Carboplatin, Cladribine, Clofarabine, Zoledronic acid, Vismodegib, Pemetrexed DiPotassium Nonahydrate, Cyclophosphamide Monohydrate and Cytarabine. It also offers AntiRetroVirals. Its non-oncology API products include Acebrophylline, Echothiophate, Nifedipine, Perfenidone, PrucaloprideSuccinate, Sildenafil Citrate, Ursodeoxycholic acid and Dimethyl Fumarate.